Reuters logo
BRIEF-Cosmo says Remimazolam successfully concludes late-stage trial
June 29, 2017 / 5:09 AM / 6 months ago

BRIEF-Cosmo says Remimazolam successfully concludes late-stage trial

June 29 (Reuters) - Cosmo Pharmaceuticals NV

* Says Remimazolam successfully concludes phase iii clinical trial for procedural sedation in bronchoscopy

* Says primary efficacy endpoint successfully achieved

* Says excellent safety profile of Remimazolam confirmed Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below